Esophageal Neoplasms: all 1,631 studies
Page 10 of 17. Open to participants first (469), then studies with results posted, then the rest; newest registration first within each.
- Microbiome Analysis in esoPhageal, PancreatIc and Colorectal CaNcer Patients Undergoing Gastrointestinal SurgeryStatus unknownNCT04189393
- Cost Effectiveness of an Intervention in Hospitalized Patients With Disease-related MalnutritionCompletedNCT04188990Not applicable
- Neoadjuvant Chemoradiotherapy Combined With PD-1 Antibody in Locally Advanced Esophageal CancerStatus unknownNCT04177875Phase 2
- Study of Endostar Combined With TP Regimen for Esophageal CancerStatus unknownNCT04164797Phase 4
- A Study of PET Scans With the Radioactive Tracer 18F-BMS-986229 in Patients With Esophageal, Stomach, or Gastroesophageal Junction CancerCompletedNCT04161781
- Cetuximab - IRDye800 Intraoperative Fluorescence Imaging in Esophagectomy of Esophageal CancerStatus unknownNCT04161560Phase 1
- RICE: Radio-Immuno-Chemotherapy of Cancer of the EsophagusActive, not recruitingNCT04159974Phase 2
- Classification of Adenocarcinoma of the Esophagogastric JunctionStatus unknownNCT04151524
- Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer TissuesActive, not recruitingNCT04147494Early Phase 1
- Frailty In Thoracic Surgery for Esophageal CancerStatus unknownNCT04145726
- Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLCActive, not recruitingNCT04140526Phase 1/2
- Sintilimab and Nab-paclitaxel in Second-line Treatment of Advanced Gastric or Gastro-oesophageal Junction AdenocarcinomaStatus unknownNCT04140318Phase 2
- Efficacy and Safety of Neo-CRT Followed Surgery Compared With Definitive CRT in Patients With Initial Unresectable ESOStatus unknownNCT04137679Phase 2
- Automatic Diagnosis of Early Esophageal Squamous Neoplasia Using pCLE With AICompletedNCT04136236
- Mediastinoscopy-assisted Transhiatal Esophagectomy Versus Thoraco-laparoscopic Esophagectomy for Esophageal CancerStatus unknownNCT04125849Not applicable
- Focused Ultrasound Ablation and PD-1 Antibody Blockade in Advanced Solid TumorsTerminatedNCT04116320Phase 1
- PD-1 Antibody + XELOX in 1st Line Serum A-fetoprotein (AFP)-Elevated Gastric or Gastroesophageal Junction AdenocarcinomaStatus unknownNCT04098796Phase 2
- Dose Escalated Adaptive RadioTherapy in Definitive Chemo-radiotherapy for Esophageal CancerTerminatedNCT04086901Not applicable
- The Efficacy of Immunodetection Point Inhibitors for Advanced Esophageal CancerStatus unknownNCT04074447
- Impedance Spectroscopy in Esophageal CancerCompletedNCT04046601Not applicable
- Radiation Dose Intensification With Accelerated Hypofractionated Intensity Modulated Radiation Therapy and Concurrent Carboplatin and Paclitaxel for Inoperable Esophageal CancerActive, not recruitingNCT04046575Phase 1
- ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS)Active, not recruitingNCT04044859Phase 1
- Medical Consortium for Screening Upper Gastrointestinal Cancers With Magnetically Controlled Capsule GastroscopyStatus unknownNCT04032353Not applicable
- Nutritional Supplementation in Reducing Complications in Patients With Locally Advanced Esophageal Cancer Undergoing Chemotherapy, Radiation Therapy, and/or SurgeryWithdrawnNCT04029857Phase 3
- The Registry of Oncology Outcomes Associated with Testing and TreatmentCompletedNCT04028479
- Neoadjuvant Chemotherapy or Chemoradiotherapy in Resectable Oesophageal Carcinoma（NewEC Study）CompletedNCT04027543
- Monitoring Efficacy of Radiotherapy in Lung Cancer and Esophageal CancerStatus unknownNCT04014465
- Combination of Toripalimab and Neoadjuvant Chemoradiotherapy in Esophageal CancerStatus unknownNCT04006041Phase 2
- Combination of Toripalimab and Chemoradiotherapy in Esophageal CancerCompletedNCT04005170Phase 2
- Rucaparib Plus Ramucirumab With or Without Nivolumab in Advanced Gastric and Esophageal AdenocarcinomaStatus unknownNCT03995017Phase 1/2
- SOX-based CRT for Esophageal Cancer.WithdrawnNCT03991104Phase 1/2
- Simultaneous Integrated Boost for Mediastinal Lymph Node Recurrence After Radical Surgery of Esophageal CancerStatus unknownNCT03990532Not applicable
- Financial Navigation Intervention in Improving Financial and Clinical Outcomes in Patients With Newly Diagnosed Gastric or Gastroesophageal Junction AdenocarcinomaCompletedNCT03986502Not applicable
- Teripalimab Plus Chemotherapy in Local Advanced Esophageal CancerStatus unknownNCT03985670Phase 2
- Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer.Active, not recruitingNCT03983954Phase 1
- Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal AdenocarcinomaCompletedNCT03961945Not applicable
- Sintilimab in Combination With Chemotherapy in Neoadjuvant Treatment of Potentially Resectable Esophageal CancerStatus unknownNCT03946969Phase 2
- Autologous CAR-T/TCR-T Cell Immunotherapy for Solid MalignanciesStatus unknownNCT03941626Phase 1/2
- A Study of Sintilimab Plus Chemoradiation Before Surgery for Esophageal CancerStatus unknownNCT03940001Early Phase 1
- Pre-Surgery If Needed for Oesophageal CancerCompletedNCT03937362
- High Dose PET/CT-guided Intensity Modulated Radiotherapy and Concurrent Chemotherapy in Esophageal CancerStatus unknownNCT03936179Not applicable
- A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal CancerCompletedNCT03929666Phase 2
- Exploration and Verification of DNA Methylolation in Early Screening of Esophageal CancerStatus unknownNCT03922230
- 2D-radiotherapy in Palliation of Advanced Esophageal CancerCompletedNCT03922152Not applicable
- IMRT With Carboplatin Versus IMRT With Carboplatin and Fluorouracil for Eldly Esophageal Cancer PatientsStatus unknownNCT03910634Phase 2
- Clinical Research on the Effect of Aspirin on the Disease Free Survival Rate of Esophageal CarcinomaStatus unknownNCT03900871Early Phase 1
- The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)Status unknownNCT03896958
- Laparoscopic Ischemic Conditioning Prior to EsophagectomyCompletedNCT03896399Not applicable
- First-line Esophageal Carcinoma Study With Chemo vs. Chemo Plus Pembrolizumab (MK-3475-590/KEYNOTE-590)-China Extension StudyWithdrawnNCT03881111Phase 3
- Detection of Early Esophageal Cancer by NIR-FME.Status unknownNCT03877601Phase 2
- A Study of AK104, a PD-1/CTLA-4 Bispecific Antibody, for Advanced Solid Tumors or With mXELOX/XELOX as First-line Therapy for Advanced Gastric or GEJ AdenocarcinomaCompletedNCT03852251Phase 1/2
- The Bacterial Composition of the Stomach in Reflux DiseaseActive, not recruitingNCT03835663
- Oesophagectomy and Chest Wall and Respiratory FunctionTerminatedNCT03835273
- TreatmENT of AnastomotiC Leakage After EsophagectomyCompletedNCT03829098
- Toripalimab as Monotherapy for Patients With Small Cell Carcinoma of Esophagus Who Failed ChemotherapyStatus unknownNCT03811379Phase 2
- Short Course Radiation Therapy in Palliative Treatment of Esophageal CancerStatus unknownNCT03804203Not applicable
- The Ave-CRT Study for Newly Diagnosed Metastatic Esophageal Squamous Cell CarcinomaStatus unknownNCT03800953Phase 2
- DRIHNC - Dehydration Reduction in Head & Neck CancerCompletedNCT03799380Not applicable
- Prehabilitation in Esophageal Surgery (PRESS)TerminatedNCT03798951Not applicable
- PET Imaging-guided Chemoradiotherapy in Esophageal Squamous Cell CarcinomaStatus unknownNCT03791905Phase 2
- A Study of Second-line Treatment of Postoperative Recurrence and Metastasis of Esophageal Cancer Treated With ApatinibWithdrawnNCT03787251Phase 2
- Study to Evaluate Efficacy of PDR001 in Patients With Squamous Cell Carcinoma of the EsophagusStatus unknownNCT03785496Phase 2
- Association of Radiochemotherapy and Immunotherapy for the Treatment of Unresectable Oesophageal caNcerCompletedNCT03777813Phase 2
- A Trial to Evaluate the Efficacy of Poziotinib, Pan HER Inhibitor in Recurrent/Metastatic Esophageal Cancer (R/M ESCC)Status unknownNCT03770988Phase 2
- Liposomal iRInotecan, Carboplatin or oXaliplatin for Esophagogastric CancerActive, not recruitingNCT03764553Phase 2
- Study With Paclitaxel +/- Ramucirumab in Patients With Squamous-cell Carcinoma of the Esophagus After Prior TherapyCompletedNCT03762564Phase 2
- HPPH Photodynamic Therapy for Patients With Esophageal CancerStatus unknownNCT03757754Phase 1
- EffectiveNess of Low-dose Aspirin in Prevention of Cancer in the Stomach and Oesophagus (GastrointEstinal Cancer Prevention) - United Kingdom ("ENgAGE - UK"): Study to Evaluate the Risk of Cancer in the Stomach and Oesophagus Among New Users of Low-dose Aspirin Using the THIN Database in the UKCompletedNCT03743883
- MM-398 and Ramucirumab in Treating Patients With Gastric Cancer or Gastroesophageal Junction AdenocarcinomaWithdrawnNCT03739801Phase 1/2
- Robotic Versus Thoracolaparoscopic Esophagectomy for Esophageal CancerStatus unknownNCT03727126Not applicable
- Vactosertib in Combination with Pembrolizumab in Metastatic Colorectal or Gastric CancerCompletedNCT03724851Phase 1/2
- Early Support in Primary Care for People Starting Treatment for CancerCompletedNCT03719716Not applicable
- A Study to Compare Efficacy and Safety of DRT VS CRT Plus Surgery in Patients Who Achieved CCR for Esophageal CancerStatus unknownNCT03708042Phase 3
- CAR T and PD-1 Knockout Engineered T Cells for Esophageal CancerStatus unknownNCT03706326Phase 1/2
- Study of SHR-1210 in Combination With Chemotherapy in Advanced Esophageal CancerCompletedNCT03691090Phase 3
- Assessing Timing of Enteral Feeding Support in Esophageal Cancer Patients on Muscle functTion and SurvivalTerminatedNCT03676478Not applicable
- Status of Superficial Esophageal Cancers Treated by Endoscopy "OESOFARE"CompletedNCT03674801
- Combination of Chemotherapy Plus RT and SHR-1210 to Treat Patients With ESCCStatus unknownNCT03671265Not applicable
- Radical Resection of Single-hole Inflatable Mediastinal Mirror Synchronization With Laparoscopic Esophageal CarcinomaStatus unknownNCT03657914Not applicable
- Do Changes in ctDNA Predict Response for Patients With Oesophageal Cancer Receiving DurvalumabActive, not recruitingNCT03653052Phase 2
- Endostatin Combined With Chemotherapy for Adjuvant Treatment of Esophageal CancerStatus unknownNCT03649945Phase 2
- The Application of Fluorescence Laparoscopy in the Treatment of Adenocarcinoma of the Esophagogastric JunctionStatus unknownNCT03647540Not applicable
- Venous Thromboembolism and Bleeding Risk in Patients With Esophageal CancerCompletedNCT03646409
- The Comparison of Single and Multi-incision MIE for Esophageal CancerStatus unknownNCT03646110Not applicable
- Autologous CAR-T/TCR-T Cell Immunotherapy for MalignanciesStatus unknownNCT03638206Phase 1/2
- The Application of 3T MRI in Esophageal CancerStatus unknownNCT03635619
- Impact of Cancer Therapy on Myocardial Function in Patients With Esophagus CancerStatus unknownNCT03619317
- PG2 Concurrent With Chemoradiation for Locally Advanced Esophageal CancerCompletedNCT03611712Phase 2
- Raltitrexed Concurrent With Radiotherapy for Elderly Chinese Patients With Squamous Cell Carcinoma of EsophagusStatus unknownNCT03585530Phase 2
- Neoadjuvant Chemotherapy Followed by Preoperative Chemoradiation in Resectable Squamous-cell Esophageal CancerStatus unknownNCT03579004Phase 2
- Contrast-Enhanced Ultrasound Identification of Sentinel Nodes in Esophageal CancerCompletedNCT03578224Early Phase 1
- A Trial Comparing Transversus Abdominis Plane Catheter Versus Epidural After EsophagectomyTerminatedNCT03570996Not applicable
- Fluorescence Endoscopy of Esophageal CarcinomaTerminatedNCT03558724Phase 1
- Evaluation of Ocoxin®-Viusid® in Advanced Stomach Cancer and Gastric Esophagogastric JunctionCompletedNCT03549494Phase 2
- Safety and Feasibility of Irradiation and Nivolumab in Esophageal Cancer (INEC)Active, not recruitingNCT03544736Phase 1/2
- Apatinib as First -Line Treatment for Advanced Esophagus CancerStatus unknownNCT03542422Phase 2
- Audit of the Spanish EURECCA Esophagogastric Cancer RegistryCompletedNCT03541629
- Endoscopic Injection of Mitomycin C for the Treatment of Pharyngoesophageal StenosisTerminatedNCT03540953Not applicable
- High-dose Intensity Modulated Radiotherapy and Concurrent Chemotherapy in Esophageal CancerStatus unknownNCT03535207Not applicable
- FOLFIRI Alternate With FOLFOX in Untreated Metastatic Gastric and Esophageal AdenocarcinomaTerminatedNCT03528876Phase 2